Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2016, Article ID 6312621, 3 pages
http://dx.doi.org/10.1155/2016/6312621
Case Report

Prolactinoma: A Massive Effect on Bone Mineral Density in a Young Patient

Warren Alpert Medical School, Brown University, 900 Warren Avenue, Suite 300, East Providence, RI 02914, USA

Received 4 April 2016; Revised 12 June 2016; Accepted 21 June 2016

Academic Editor: Hidetoshi Ikeda

Copyright © 2016 Scott Sperling and Harikrashna Bhatt. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Shoback, D. Sellmeyer, and D. Bikle, “Metabolic bone disease,” in Greenspan's Basic and Clinical Endocrinology, D. G. Gardner and D. Shoback, Eds., pp. 321–329, McGraw Hill, New York, NY, USA, 2007. View at Google Scholar
  2. J. R. Center, T. V. Nguyen, D. Schneider, P. N. Sambrook, and J. A. Eisman, “Mortality after all major types of osteoporotic fracture in men and women: an observational study,” The Lancet, vol. 353, no. 9156, pp. 878–882, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. L. Lu-Yao, J. A. Baron, J. A. Barrett, and E. S. Fisher, “Treatment and survival among elderly Americans with hip fractures: a population-based study,” American Journal of Public Health, vol. 84, no. 8, pp. 1287–1291, 1994. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Johnell and J. A. Kanis, “WHO scientific group on the assessment of osteoporosis at primary health care level,” in Proceedings of the Summary Meeting Report, Brussels, Belgium, May 2007.
  5. P. R. Ebeling, “Osteoporosis in men,” The New England Journal of Medicine, vol. 358, no. 14, pp. 1474–1482, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Klibanski, “Prolactinomas,” The New England Journal of Medicine, vol. 362, no. 13, pp. 1219–1226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. L. Greenspan, R. M. Neer, E. C. Ridgway, and A. Klibanski, “Osteoporosis in men with hyperprolactinemic hypogonadism,” Annals of Internal Medicine, vol. 104, no. 6, pp. 777–782, 1986. View at Publisher · View at Google Scholar · View at Scopus
  8. T. Dandinoğlu, S. Akarsu, L. Tekin, S. Arbal, and Ü. Dinçer, “A 22-year-old man with severe osteoporosis due to prolactinoma,” Journal of Clinical Rheumatology, vol. 19, no. 6, pp. 341–343, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. E. C. O. Naliato, M. L. F. Farias, G. R. Braucks, F. S. R. Costa, D. Zylberberg, and A. H. D. Violante, “Prevalence of osteopenia in men with prolactinoma,” Journal of Endocrinological Investigation, vol. 28, no. 1, pp. 12–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Greenspan, D. S. Oppenheim, and A. Klibanski, “Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism,” Annals of Internal Medicine, vol. 110, no. 7, pp. 526–531, 1989. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Seriwatanachai, N. Krishnamra, and J. P. T. M. Van Leeuwen, “Evidence for direct effects of prolactin on human osteoblasts: inhibition of cell growth and mineralization,” Journal of Cellular Biochemistry, vol. 107, no. 4, pp. 677–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Mazziotti, T. Porcelli, M. Mormando et al., “Vertebral fractures in males with prolactinoma,” Endocrine, vol. 39, no. 3, pp. 288–293, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Mazziotti, T. Mancini, M. Mormando et al., “High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas,” Pituitary, vol. 14, no. 4, pp. 299–306, 2011. View at Publisher · View at Google Scholar · View at Scopus